XIFAXAN® 550mg (rifaximin-?) Registered for Reduction of Recurrence of Episodes of Overt Hepatic Encephalopathy in the EU*
Bologna, Italy And Amsterdam (ots/PRNewswire) - Alfa Wassermann and Norgine are pleased to announce that they have received European Marketing Authorisation for XIFAXAN(R) 550mg (rifaximin-alpha) / REFERO(R) / TARGAXAN(R) / TIXTELLER(R) in the reduction of recurrence of episodes of overt hepatic encephalopathy (HE) ...
plus